New York, May 22, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions. The metabolomics market is segmented on the lines of its technique, application and indication. The metabolomics market is segmented on the lines of its technique like separation techniques and detection techniques. The separation techniques is further divided into gas chromatography (GC), capillary electrophoresis (CE), high performance liquid chromatography (HPLC) and ultra performance liquid chromatography (UPLC). Detection techniques covers nuclear magnetic resonance spectroscopy (NMR), mass spectrometry (MS) and surface based mass analysis. The metabolomics market is segmented on the lines of its applications into biomarker, discovery, drug discovery/drug assessment, toxicology testing and nutria genomics. Under indication segmentation it covered oncology, neurology and cardiology. The metabolomics market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The metabolomics market is projected to cross USD 2.0 Billion in the given forecasted period. North America contributed up to 45% of market share making it a market leader in metabolomics market. Europe is second largest market with up to 39% of the market share. Asia-Pacific will grow at remarkable CAGR i.e. 24% during the forecast period. Increasing penetration of pharmaceutical products is stimulating the APAC market.
You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/metabolomics-market
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, Agilent Technologies, Metabolon, Inc., Shimadzu Corporation, Bruker Corporation and Biocrates Life Sciences AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The scope of the report includes a detailed study of global and regional markets for various types of metabolomics market with the reasons given for variations in the growth of the industry in certain regions.
Metabolomics is scientific term in which technical study of metabolites which is small molecules, biological cell, biofluids, tissue and organs. Metabolomics is also used to explain rising skill of measurement and study of metabolites like sugar & fat within the cell of organs by definite period and in definite situation. Metabolomics is having the common characteristics with computer science technology, mathematics, chemistry and biology. Metabolomics is important to medical doctor for the reason that it can guide to progress in the finding and treatments of person diseases. Analytical equipments and different software are very important object in metabolomics field.
This report provides:
1) An overview of the global market for metabolomics and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for metabolomics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of metabolomics market are as follows:
o Rising research funding and administration support drives the market growth.
o Use in biotechnology and pharmaceutical area spur the metabolomics research.
o Growing requirement of personalized medication within healthcare industry.
o Increasing requirement for toxicity equipment.
The restraints factors of metabolomics market are as follows:
o Data examination and data processing.
o Low acceptance rate.
The Metabolomics Market has been segmented as below:
The Global Metabolomics Market this market is segmented on the basis of Technique Analysis, Application Analysis, Indication Analysis and Regional Analysis.
By Technique Analysis this market is segmented on the basis of Separation Techniques, Gas Chromatography (GC), Capillary Electrophoresis (CE), High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Detection Techniques, Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS) and Surface Based Mass Analysis. By Application Analysis this market is segmented on the basis of Biomarker Discovery, Drug Discovery/Drug Assessment, Toxicology Testing, Nutrigenomics and Others. By Indication Analysis this market is segmented on the basis of Oncology, Neurology, Cardiology and Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Request Sample Report: https://www.marketresearchengine.com/reportdetails/metabolomics-market
Table of Contents
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
220.127.116.11 Key Data From Secondary Sources
2.1.2 Primary Research
18.104.22.168 Key Data From Primary Sources
22.214.171.124 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Technology Investment Potential
8 Global Metabolomics Market, By Product and Service
9 Global Metabolomics Market, By Application
10 Global Metabolomics Market, By Indication
11 Global Metabolomics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 Thermo Fisher Scientific Inc.
13.3 Agilent Technologies, Inc.
13.4 Waters Corporation
13.5 Danaher Corporation
13.6 Shimadzu Corporation
13.7 Biocrates Life Sciences AG
13.8 Bio-Rad Laboratories, Inc.
13.9 Bruker Corporation
13.10 Human Metabolome Technologies, Inc.
13.11 Leco Corporation
13.12 Metabolon, Inc.
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States